Researchers show the direct relationship between AGE proteins and prediction of cardiovascular risk in the early stages of renal disease
A non-invasive and rapid test allows the identification of advanced glycation products, Advanced Glycation End Products (AGE), proteins that emit fluorescence and predict mortality in renal patients
Lleida, March 13rd, 2017
Researchers at the Arnau University Hospital in Vilanova de Lleida, the University of Lleida and the Biomedical Research Institute of Lleida Dr. Pifarré Foundation (IRBLleida) have demonstrated the direct relationship between proteins called advanced glycation end products Advanced Glycation End Products ) In the process of formation of atheromatous (fatty) plaques in the arteries in renal patients, a relationship that allows accurate assessment of the actual cardiovascular risk in the early stages of chronic kidney disease. This finding, which has been published recently in the scientific journal PlosOne, has been led by the Basic and Clinical Group of Immunology and Endocrinology and by researchers from the Unit UDETMA (Unit of Diagnosis and Treatment of Atherothrombotic Diseases) of the IRBLleida.
